Ernest H. Schell

Learn More
Cyclo-oxygenase-2 selective inhibitors are frequently used to manage osteoarthritis. We compared the analgesic efficacy of the novel cyclo-oxygenase-2 selective inhibitor lumiracoxib (Prexige) versus placebo and celecoxib in patients with knee osteoarthritis. This seven day, double-blind, placebo and active comparator controlled, parallel group study(More)
I have been asked by the LEO Foundation to review today the history of business computing during the last 50 years. I want to begin by thanking you very much for the honour of addressing this distinguished group. Since 2001, when we celebrated the first half-century of business computing, so much has changed that it is a tribute to the LEO Foundation that(More)
  • 1